Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$4.58 - $7.14 $65,045 - $101,402
-14,202 Closed
0 $0
Q3 2020

Nov 04, 2020

BUY
$4.19 - $6.69 $59,506 - $95,011
14,202 New
14,202 $77,000
Q1 2020

Apr 21, 2020

SELL
$2.67 - $4.97 $29,949 - $55,748
-11,217 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$2.93 - $4.5 $293 - $450
100 Added 0.9%
11,217 $45,000
Q3 2019

Nov 07, 2019

SELL
$3.08 - $5.76 $9,240 - $17,280
-3,000 Reduced 21.25%
11,117 $48,000
Q2 2019

Aug 06, 2019

SELL
$3.47 - $6.32 $16,482 - $30,020
-4,750 Reduced 25.18%
14,117 $56,000
Q1 2019

May 06, 2019

BUY
$5.36 - $7.24 $13,400 - $18,100
2,500 Added 15.27%
18,867 $101,000
Q4 2018

Feb 11, 2019

SELL
$4.8 - $11.6 $4,320 - $10,440
-900 Reduced 5.21%
16,367 $84,000
Q3 2018

Nov 14, 2018

SELL
$9.05 - $10.95 $3,167 - $3,832
-350 Reduced 1.99%
17,267 $167,000
Q2 2018

Jul 30, 2018

BUY
$10.2 - $13.9 $5,100 - $6,950
500 Added 2.92%
17,617 $180,000
Q1 2018

Apr 16, 2018

BUY
$12.65 - $18.85 $216,530 - $322,655
17,117 New
17,117 $223,000
Q4 2017

Feb 09, 2018

SELL
$17.45 - $25.6 $194,270 - $285,004
-11,133 Closed
0 $0
Q3 2017

Oct 26, 2017

BUY
$18.9 - $28.2 $210,413 - $313,950
11,133
11,133 $279,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.